NCT06060587 2025-10-22Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + AbirateroneNorthwestern UniversityPhase 2 Withdrawn
NCT04419181 2025-10-14Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast CancerUniversity of RochesterPhase 2 Withdrawn